Valuation: Novartis AG

Market Cap 277B 242B 224B 205B 389B 26,682B 395B 2,669B 1,049B 13,030B 1,040B 1,017B 44,984B P/E 2026 *
21.1x
P/E 2027 * 17.9x
Enterprise Value 309B 270B 250B 229B 434B 29,765B 441B 2,978B 1,170B 14,535B 1,160B 1,135B 50,182B EV / Sales 2026 *
5.43x
EV / Sales 2027 * 5.06x
Free-Float
91.66%
Yield 2026 *
2.91%
Yield 2027 * 3%
1 day+0.84%
1 week-0.84%
Current month-2.62%
1 month+2.97%
3 months+4.97%
6 months+6.63%
Current year+12.46%
1 week 121.06
Extreme 121.06
125.8
1 month 117.96
Extreme 117.96
128.92
Current year 107.68
Extreme 107.68
131
1 year 91.2
Extreme 91.2
131
3 years 81.1
Extreme 81.1
131
5 years 72.84
Extreme 72.84
131
10 years 65.09
Extreme 65.09
131
Manager TitleAgeSince
Chief Executive Officer 50 01/02/2018
Director of Finance/CFO - 16/03/2026
Chief Tech/Sci/R&D Officer 64 16/05/2022
Director TitleAgeSince
Director/Board Member 67 01/01/2015
Director/Board Member 69 01/01/2016
Director/Board Member 61 01/01/2016
Date Insider Type Main position Quantity % Market Cap.
5/18/26 A Sell -5,200 0.0003%
5/4/26 A Sell 6,800 0.0003%
2/17/26 A Sell 30,743 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
+1.03%-0.84%+29.58%+45.15% 277B
+1.17%-3.39%+48.86%+162.94% 1,031B
+0.80%-3.57%+51.63%+57.08% 595B
+2.99%+0.78%+32.16%+86.81% 431B
+0.42%-1.16%+29.43%+23.64% 326B
+0.49%-5.44%+21.00%+23.80% 263B
+1.59%+4.89%-22.56%-37.35% 224B
+2.65%+1.28%+23.16%+61.63% 193B
+1.67%-0.89%+21.66%+72.48% 164B
+1.11%+3.65%+2.13%-29.91% 141B
Average +1.32%-3.09%+23.71%+46.63% 364.58B
Weighted average by Cap. +1.26%-4.02%+33.34%+76.00%

Financials

2026 *2027 *
Net sales 56.91B 49.74B 46B 42.21B 79.89B 5,483B 81.28B 549B 216B 2,678B 214B 209B 9,245B 60.31B 52.72B 48.75B 44.74B 84.67B 5,812B 86.14B 581B 228B 2,838B 226B 222B 9,798B
Net income 14.08B 12.31B 11.38B 10.44B 19.77B 1,357B 20.11B 136B 53.32B 662B 52.87B 51.71B 2,287B 15.64B 13.67B 12.65B 11.6B 21.96B 1,507B 22.34B 151B 59.24B 736B 58.75B 57.46B 2,541B
Net Debt 32B 27.97B 25.87B 23.74B 44.92B 3,083B 45.7B 308B 121B 1,506B 120B 118B 5,198B 28.48B 24.89B 23.02B 21.13B 39.98B 2,744B 40.68B 275B 108B 1,340B 107B 105B 4,627B
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
16/07/26 CHF 123.26 +1.03% 2,306,603
15/07/26 CHF 122.00 -0.34% 1,730,393
14/07/26 CHF 122.42 -1.73% 2,431,098
13/07/26 CHF 124.58 +0.24% 2,143,959
10/07/26 CHF 124.28 -0.02% 2,334,841
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
151.27USD
Average target price
152.96USD
Spread / Average Target
+1.12%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NOVN Stock